Cargando…
Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
Polymyalgia rheumatica (PMR) and PMR-like syndromes are among the most frequent rheumatologic immuno-related adverse events (IRAEs) induced by cancer immunotherapy with “checkpoint inhibitors” (ICIs). Our short communication addresses two key methodological issues laid bare by published literature :...
Autores principales: | Manzo, Ciro, Isetta, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944960/ https://www.ncbi.nlm.nih.gov/pubmed/33707798 http://dx.doi.org/10.5114/reum.2021.102600 |
Ejemplares similares
-
Messages from the history of polymyalgia rheumatica
por: Manzo, Ciro
Publicado: (2021) -
Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months update
por: Manzo, Ciro, et al.
Publicado: (2023) -
Polymyalgia Rheumatica
por: Dixon, A. St J.
Publicado: (1969) -
Polymyalgia rheumatica
por: Rosenberg, Hans, et al.
Publicado: (2021) -
Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature
por: Manzo, Ciro, et al.
Publicado: (2022)